Oxidative stress in vascular disease and its pharmacological prevention

Trends in Pharmacological Sciences

Volumn 34, Issue 6, 2013, Pages 313-319

  Li, Huige ^a   Horke, Sven ^a   Förstermann, Ulrich ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

ACEIs; AT1 receptor antagonists; eNOS uncoupling; NADPH oxidase; oxidative stress; paraoxonase; reactive oxygen species; statins

Indexed keywords

ALPHA TOCOPHEROL; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; ASCORBIC ACID; BETA CAROTENE; CATALASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE PEROXIDASE; HEME OXYGENASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; MITOQ; NEBIVOLOL; PENTAERYTHRITYL TETRANITRATE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RESVERATROL; SUPEROXIDE DISMUTASE; TETRAHYDROBIOPTERIN; THIOREDOXIN REDUCTASE; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

ANTIOXIDANT ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; GENE THERAPY; HEART MUSCLE ISCHEMIA; HEPATITIS C; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; IN-STENT RESTENOSIS; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY CHAIN; REVIEW; SMOKING; VASCULAR DISEASE;

ANIMALS; ANTIOXIDANTS; HUMANS; OXIDATIVE STRESS; VASCULAR DISEASES;

EID: 84878525986     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2013.03.007     Document Type: Review

References (74)

1. U. Forstermann Nitric oxide and oxidative stress in vascular disease Pflugers Arch. 459 2010 923 939
2. G.R. Drummond Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets Nat. Rev. Drug Discov. 10 2011 453 471
3. K. Matsuno Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice Circulation 112 2005 2677 2685
4. A. Dikalova Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice Circulation 112 2005 2668 2676
5. P.A. Barry-Lane p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice J. Clin. Invest. 108 2001 1513 1522
6. C.R. White Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits Proc. Natl. Acad. Sci. U.S.A. 93 1996 8745 8749
7. Y. Ohara Hypercholesterolemia increases endothelial superoxide anion production J. Clin. Invest. 91 1993 2546 2551
8. S.M. Davidson, and M.R. Duchen Endothelial mitochondria: contributing to vascular function and disease Circ. Res. 100 2007 1128 1141
9. E. Schulz Mitochondrial redox signaling: interaction of mitochondrial reactive oxygen species with other sources of oxidative stress Antioxid. Redox Signal. 2012 10.1089/ars.2012.4609
10. M. Zeini Differential sensitivity to apoptosis among the cells that contribute to the atherosclerotic disease Biochem. Biophys. Res. Commun. 363 2007 444 450
11. N.R. Madamanchi, and M.S. Runge Mitochondrial dysfunction in atherosclerosis Circ. Res. 100 2007 460 473
12. Y. Li Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase Nat. Genet. 11 1995 376 381
13. U. Förstermann Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies Nat. Clin. Pract. Cardiovasc. Med. 5 2008 338 349
14. U. Förstermann, and W.C. Sessa Nitric oxide synthases: regulation and function Eur. Heart J. 33 2012 829 837 837a-837d
15. Y. Zhang Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived H2O2 Hypertension 46 2005 732 737
16. T. Yoshida Glutathione peroxidase knockout mice are susceptible to myocardial ischemia reperfusion injury Circulation 96 1997 II-216 II-220
17. M. Torzewski Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice Arterioscler. Thromb. Vasc. Biol. 27 2007 850 857
18. S. Blankenberg Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease N. Engl. J. Med. 349 2003 1605 1613
19. R. Stocker, and M.A. Perrella Heme oxygenase-1: a novel drug target for atherosclerotic diseases? Circulation 114 2006 2178 2189
20. F. Jiang NO modulates NADPH oxidase function via heme oxygenase-1 in human endothelial cells Hypertension 48 2006 950 957
21. C. Berndt Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system Am. J. Physiol. Heart Circ. Physiol. 292 2007 H1227 H1236
22. I. Witte Protectors or traitors: the roles of PON2 and PON3 in atherosclerosis and cancer J. Lipids 2012 2012 342806
23. S. Horke Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation Circulation 115 2007 2055 2064
24. C.J. Ng Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2 J. Biol. Chem. 281 2006 29491 29500
25. S. Altenhofer One enzyme, two functions: PON2 prevents mitochondrial superoxide formation and apoptosis independent from its lactonase activity J. Biol. Chem. 285 2010 24398 24403
26. A. Devarajan Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis Antioxid. Redox Signal. 14 2011 341 351
27. E.M. Schweikert PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death Cell Death Differ. 19 2012 1549 1560
28. D.M. Shih Decreased obesity and atherosclerosis in human paraoxonase 3 transgenic mice Circ. Res. 100 2007 1200 1207
29. H. Li Reversal of endothelial nitric oxide synthase uncoupling and up-regulation of endothelial nitric oxide synthase expression lowers blood pressure in hypertensive rats J. Am. Coll. Cardiol. 47 2006 2536 2544
30. U. Landmesser Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension J. Clin. Invest. 111 2003 1201 1209
31. K. Chalupsky, and H. Cai Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase Proc. Natl. Acad. Sci. U.S.A. 102 2005 9056 9061
32. T.J. Guzik Coronary artery superoxide production and nox isoform expression in human coronary artery disease Arterioscler. Thromb. Vasc. Biol. 26 2006 333 339
33. K.A. Pritchard Jr Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion Circ. Res. 77 1995 510 518
34. D.W. Stepp Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ Am. J. Physiol. Heart Circ. Physiol. 283 2002 H750 H759
35. N. Xia Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice J. Pharmacol. Exp. Ther. 335 2010 149 154
36. E. Stroes Tetrahydrobiopterin restores endothelial function in hypercholesterolemia J. Clin. Invest. 99 1997 41 46
37. G. Nickenig Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men Circulation 100 1999 2131 2134
38. E.A. Jaimes Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation Arterioscler. Thromb. Vasc. Biol. 24 2004 1031 1036
39. A. Csiszar Oxidative stress and accelerated vascular aging: implications for cigarette smoking Front. Biosci. 14 2009 3128 3144
40. Y. Steffen Cigarette smoke and LDL cooperate in reducing nitric oxide bioavailability in endothelial cells via effects on both eNOS and NADPH oxidase Nitric Oxide 27 2012 176 184
41. T. Heitzer Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: evidence for a dysfunctional nitric oxide synthase Circ. Res. 86 2000 E36 E41
42. F. Giacco, and M. Brownlee Oxidative stress and diabetic complications Circ. Res. 107 2010 1058 1070
43. S.D. Funk Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes Int. J. Vasc. Med. 2012 2012 569654
44. U. Hink Mechanisms underlying endothelial dysfunction in diabetes mellitus Circ. Res. 88 2001 E14 E22
45. W.T. Wong Angiotensin II type 1 receptor-dependent oxidative stress mediates endothelial dysfunction in type 2 diabetic mice Antioxid. Redox Signal. 13 2010 757 768
46. T. Imanishi Addition of eplerenone to an angiotensin-converting enzyme inhibitor effectively improves nitric oxide bioavailability Hypertension 51 2008 734 741
47. T. Takaya Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice Atherosclerosis 186 2006 402 410
48. P. Wenzel AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats Free Radic. Biol. Med. 45 2008 619 626
49. J.H. Oak, and H. Cai Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice Diabetes 56 2007 118 126
50. M. Knorr Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan Arterioscler. Thromb. Vasc. Biol. 31 2011 2223 2231
51. B. Hornig Comparative effect of ACE inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase Circulation 103 2001 799 805
52. P. Wenzel Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus Atherosclerosis 198 2008 65 76
53. C. Antoniades Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity Circulation 122 2010 S66 S73
54. M.M. Carrepeiro Effect of n-3 fatty acids and statins on oxidative stress in statin-treated hypercholestorelemic and normocholesterolemic women Atherosclerosis 217 2011 171 178
55. U. Landmesser Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans Circulation 111 2005 2356 2363
56. A.S. Antonopoulos Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials Curr. Pharm. Des. 18 2012 1519 1530
57. H. Mollnau Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells Arterioscler. Thromb. Vasc. Biol. 23 2003 615 621
58. M. Oelze Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats Hypertension 48 2006 677 684
59. T. Munzel, and T. Gori Nebivolol: the somewhat-different beta-adrenergic receptor blocker J. Am. Coll. Cardiol. 54 2009 1491 1499
60. A. Pautz Effects of nitroglycerin or pentaerithrityl tetranitrate treatment on the gene expression in rat hearts: evidence for cardiotoxic and cardioprotective effects Physiol. Genomics 38 2009 176 185
61. M. Oppermann Pharmacological induction of vascular extracellular superoxide dismutase expression in vivo J. Cell. Mol. Med. 13 2009 1271 1278
62. S. Schuhmacher Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy Diabetes 60 2011 2608 2616
63. S. Schuhmacher Pentaerythritol tetranitrate improves angiotensin II-induced vascular dysfunction via induction of heme oxygenase-1 Hypertension 55 2010 897 904
64. H. Li Cardiovascular effects and molecular targets of resveratrol Nitric Oxide 26 2012 102 110
65. N.L. Price SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function Cell Metab. 15 2012 675 690
66. A. Csiszar Resveratrol induces mitochondrial biogenesis in endothelial cells Am. J. Physiol. Heart Circ. Physiol. 297 2009 H13 H20
67. M. Tanno Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure J. Biol. Chem. 285 2010 8375 8382
68. Q. Bin The role of vitamin E (tocopherol) supplementation in the prevention of stroke. A meta-analysis of 13 randomised controlled trials Thromb. Haemost. 105 2011 579 585
69. S.J. Newberry What is the evidence that vitamin C supplements lower blood pressure? Am. J. Clin. Nutr. 95 2012 997 998
70. D. Kirmizis, and D. Chatzidimitriou Antiatherogenic effects of vitamin E: the search for the Holy Grail Vasc. Health Risk Manag. 5 2009 767 774
71. R.A. Smith, and M.P. Murphy Animal and human studies with the mitochondria-targeted antioxidant MitoQ Ann. N. Y. Acad. Sci. 1201 2010 96 103
72. N.J. Alp Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice Arterioscler. Thromb. Vasc. Biol. 24 2004 445 450
73. J.H. Brasen Extracellular superoxide dismutase accelerates endothelial recovery and inhibits in-stent restenosis in stented atherosclerotic Watanabe heritable hyperlipidemic rabbit aorta J. Am. Coll. Cardiol. 50 2007 2249 2253
74. H. Yang Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E Circ Res. 95 2004 1075 1081